The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Disease progression in amyotrophic lateral sclerosis: Predictors of survival
Abstract
Predicting the rate of disease progression has become important as trials of new medical treatments for amyotrophic lateral sclerosis (ALS) are planned. Bulbar onset, early impairment of forced vital capacity, and older age have all been associated with shorter survival. We performed a retrospective study to compare survival factors with disease progression in a German ALS population. We analyzed disease progression in 155 patients at intervals of 4 months over a period of 3 years. To evaluate disease progression, the ALS functional rating scale (ALS‐FRS), forced vital capacity (FVC%), and a Medical Research Council (MRC) compound score based on a nine‐step modified MRC scale were used. We compared age (<55 years vs. ≥55 years), different sites of disease onset (bulbar vs. limb), and gender to the rate of disease progression and performed survival analyses. No overall significant difference could be detected when analyzing these subgroups with regard to disease progression. By contrast, significantly longer survival was observed in the younger age group (56 months vs. 38 months, P < 0.0001) and in patients with limb‐onset disease (51 months vs. 37 months, P = 0.0002). Using Cox analyses values we found that the declines of ALS‐FRS, FVC%, and MRC compound score were predictive of survival (P < 0.0001, P = 0.002, and P = 0.003, respectively). Future studies are needed to clarify whether nonspecific factors including muscle atrophy, dysphagia, and coexisting diseases influence prediction of survival in ALS patients. A more precise set of predictors may help to better stratify patient subgroups for future treatment trials. © 2002 Wiley Periodicals, Inc. Muscle Nerve 25:000–000, 2002
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Cited by
Prognostic factors in ALS: A critical review
Chiò, A., Logroscino, G., Hardiman, O., Swingler, R., Mitchell, D., Beghi, E., Traynor, B. G., & On Behalf of the Eurals Consortium (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802566824 · Cited by 1,172
A comprehensive review of amyotrophic lateral sclerosis
Zarei, S., Carr, K., Reiley, L., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.169561 · Cited by 709
ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration
Ravits, J. M., & La Spada, A. R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bbbd · Cited by 604
Effects of gender in amyotrophic lateral sclerosis
McCombe, P. A., & Henderson, R. D. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.11.010 · Cited by 379
Czaplinski, A. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.072660 · Cited by 273
Early symptom progression rate is related to ALS outcome: A prospective population-based study
Chiò, A., Mora, G., Leone, M., Mazzini, L., Cocito, D., Giordana, M. T., Bottacchi, E., & Mutani, R. (2002) · Neurology · doi:10.1212/wnl.59.1.99 · Cited by 266
ALSFRS-R score and its ratio: A useful predictor for ALS-progression
Kollewe, K., Mauss, U., Krampfl, K., Petri, S., Dengler, R., & Mohammadi, B. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.07.016 · Cited by 253
“Covariates of survival are age of onset, site of onset, respiratory function and time from symptom onset to diagnosis [3–10].”
BackgroundResultInfluentialExcess incidence of ALS in young Gulf War veterans
Haley, R. W. (2003) · Neurology · doi:10.1212/wnl.61.6.750 · Cited by 227
Prospective study of military service and mortality from ALS
Weisskopf, M. G., O’Reilly, E. J., McCullough, M. L., Calle, E. E., Thun, M. J., Cudkowicz, M., & Ascherio, A. (2005) · Neurology · doi:10.1212/01.wnl.0000148649.17706.d9 · Cited by 197
Prospective Study of Cigarette Smoking and Amyotrophic Lateral Sclerosis
Weisskopf, M. G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh179 · Cited by 154
Fitzgerald, K. C., O'Reilly, É. J., Fondell, E., Falcone, G. J., McCullough, M. L., Park, Y., Kolonel, L. N., & Ascherio, A. (2013) · Annals of Neurology · doi:10.1002/ana.23820 · Cited by 91
Coping strategies as related to medical and demographic data in amyotrophic lateral sclerosis
Montel, S., Albertini, L., & Spitz, E. (2012) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01513.x · Cited by 61
Wolf, J., Safer, A., Wöhrle, J. C., Palm, F., Nix, W. A., Maschke, M., & Grau, A. J. (2014) · BMC Neurology · doi:10.1186/s12883-014-0197-9 · Cited by 60
Prospective Study of Occupation and Amyotrophic Lateral Sclerosis Mortality
Weisskopf, M. G., McCullough, M. L., Morozova, N., Calle, E. E., Thun, M. J., & Ascherio, A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi343 · Cited by 55
Brady, C. B., Trevor, K. T., Stein, T. D., Deykin, E. Y., Perkins, S. D., Averill, J. G., Guilderson, L., Mckee, A. C., Renner, S. W., & Kowall, N. W. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.822516 · Cited by 19
Metadata
- Authors
- Magnus, T., Beck, M., Giess, R., Puls, I., Naumann, M., & Toyka, K. V.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2002-04-03
- Volume
- 25
- Issue
- 5
- Pages
- 709-714
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2117991410
- Cited by
- 222
- References
- 1
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.